260 related articles for article (PubMed ID: 33123921)
1. Risk of serious infection, malignancy, or death in Japanese rheumatoid arthritis patients treated with a combination of abatacept and tacrolimus: a retrospective cohort study.
Tokunaga K; Matsui K; Oshikawa H; Matsui T; Tohma S
Clin Rheumatol; 2021 May; 40(5):1811-1817. PubMed ID: 33123921
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and safety of additional administration of tacrolimus in rheumatoid arthritis patients with an inadequate response to abatacept: A retrospective cohort study.
Suzuki M; Takahashi N; Kida D; Hirano Y; Kato T; Yabe Y; Oguchi T; Fujibayashi T; Hayashi M; Asai S; Ishiguro N; Kojima T
Int J Rheum Dis; 2019 Dec; 22(12):2199-2205. PubMed ID: 31647174
[TBL] [Abstract][Full Text] [Related]
3. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
Takahashi N; Fujibayashi T; Kida D; Hirano Y; Kato T; Kato D; Saito K; Kaneko A; Yabe Y; Takagi H; Oguchi T; Miyake H; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Hanabayashi M; Hirabara S; Asai S; Takemoto T; Terabe K; Asai N; Yoshioka Y; Ishiguro N; Kojima T
Rheumatol Int; 2015 Oct; 35(10):1707-16. PubMed ID: 25991396
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.
Fujibayashi T; Takahashi N; Kida D; Kaneko A; Hirano Y; Fukaya N; Yabe Y; Oguchi T; Tsuboi S; Miyake H; Takemoto T; Kawasaki M; Ishiguro N; Kojima T
Mod Rheumatol; 2015; 25(6):825-30. PubMed ID: 25775147
[TBL] [Abstract][Full Text] [Related]
5. Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis.
Sato S; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Yashiro-Furuya M; Asano T; Suzuki E; Watanabe H; Kanno T; Migita K
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577837
[No Abstract] [Full Text] [Related]
6. Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Terabe K; Takahashi N; Asai S; Hirano Y; Kanayama Y; Yabe Y; Oguchi T; Fujibayashi T; Ishikawa H; Hanabayashi M; Hattori Y; Suzuki M; Kishimoto K; Ohashi Y; Imaizumi T; Imagama S; Kojima T
Mod Rheumatol; 2023 Mar; 33(2):292-301. PubMed ID: 35289372
[TBL] [Abstract][Full Text] [Related]
7. Radiological evaluation of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept or JAK inhibitors for 1 year.
Mochizuki T; Yano K; Ikari K; Okazaki K
Respir Investig; 2023 May; 61(3):359-363. PubMed ID: 37031622
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis.
Akiyama M; Kaneko Y; Kondo H; Takeuchi T
Clin Rheumatol; 2016 Nov; 35(11):2829-2834. PubMed ID: 26971256
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.
Yamada Z; Muraoka S; Kawazoe M; Hirose W; Kono H; Yasuda S; Sugihara T; Nanki T
Arthritis Res Ther; 2024 Apr; 26(1):87. PubMed ID: 38627782
[TBL] [Abstract][Full Text] [Related]
10. Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
Temmoku J; Miyata M; Suzuki E; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Fujita Y; Matsuoka N; Asano T; Sato S; Watanabe H; Migita K
PLoS One; 2022; 17(9):e0274775. PubMed ID: 36121851
[TBL] [Abstract][Full Text] [Related]
11. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
[TBL] [Abstract][Full Text] [Related]
12. Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries.
Dominique A; Hetland ML; Finckh A; Gottenberg JE; Iannone F; Caporali R; Kou TD; Nordstrom D; Hernandez MV; Sánchez-Piedra C; Sánchez-Alonso F; Pavelka K; Bond TC; Simon TA
Arthritis Res Ther; 2023 Jun; 25(1):101. PubMed ID: 37308978
[TBL] [Abstract][Full Text] [Related]
13. Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.
Ebina K; Hashimoto M; Yamamoto W; Hirano T; Hara R; Katayama M; Onishi A; Nagai K; Son Y; Amuro H; Yamamoto K; Maeda Y; Murata K; Jinno S; Takeuchi T; Hirao M; Kumanogoh A; Yoshikawa H
PLoS One; 2019; 14(5):e0216624. PubMed ID: 31067271
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan.
Takeuchi T; Ishida K; Shiraki K; Yoshiyasu T
Mod Rheumatol; 2018 Jan; 28(1):48-57. PubMed ID: 28649878
[TBL] [Abstract][Full Text] [Related]
15. Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis receiving tacrolimus.
Park EY; Lee SG; Park EK; Koo DW; Park JH; Kim GT; Tag HS; Kim HO; Suh YS
Korean J Intern Med; 2018 Jan; 33(1):193-202. PubMed ID: 27048254
[TBL] [Abstract][Full Text] [Related]
16. [Abatacept].
Iwamoto N; Kawakami A
Nihon Rinsho; 2016 Jun; 74(6):968-73. PubMed ID: 27311187
[TBL] [Abstract][Full Text] [Related]
17. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
Pawar A; Desai RJ; Solomon DH; Santiago Ortiz AJ; Gale S; Bao M; Sarsour K; Schneeweiss S; Kim SC
Ann Rheum Dis; 2019 Apr; 78(4):456-464. PubMed ID: 30679153
[TBL] [Abstract][Full Text] [Related]
18. Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis.
Okazaki S; Watanabe R; Harigae H; Fujii H
Tohoku J Exp Med; 2020 Mar; 250(3):153-159. PubMed ID: 32132324
[TBL] [Abstract][Full Text] [Related]
19. Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study.
Simon TA; Boers M; Hochberg M; Baker N; Skovron ML; Ray N; Singhal S; Suissa S; Gomez-Caminero A
Arthritis Res Ther; 2019 Nov; 21(1):228. PubMed ID: 31703717
[TBL] [Abstract][Full Text] [Related]
20. Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
Ebina K; Hashimoto M; Yamamoto W; Hirano T; Hara R; Katayama M; Onishi A; Nagai K; Son Y; Amuro H; Yamamoto K; Maeda Y; Murata K; Jinno S; Takeuchi T; Hirao M; Kumanogoh A; Yoshikawa H
Arthritis Res Ther; 2019 Apr; 21(1):91. PubMed ID: 30971306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]